Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer
出版年份 2022 全文链接
标题
Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer
作者
关键词
-
出版物
Cells
Volume 11, Issue 23, Pages 3744
出版商
MDPI AG
发表日期
2022-11-24
DOI
10.3390/cells11233744
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive Biomarkers
- (2022) Ming-Wei Su et al. Cells
- Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
- (2022) Luis A Diaz et al. LANCET ONCOLOGY
- Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review
- (2022) Chun-Ming Huang et al. Frontiers in Oncology
- LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study
- (2022) M. Chalabi et al. ANNALS OF ONCOLOGY
- Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection
- (2021) Yan Yuan et al. BMC CANCER
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer
- (2021) Yen-Cheng Chen et al. PLoS One
- Identifying Diagnostic MicroRNAs and Investigating Their Biological Implications in Rectal Cancer
- (2021) Jin K. Kim et al. JAMA Network Open
- Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer
- (2020) Qun Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- FOxTROT: neoadjuvant FOLFOX chemotherapy with or without panitumumab (Pan) for patients (pts) with locally advanced colon cancer (CC).
- (2020) Jenny F. Seligmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
- (2020) Myriam Chalabi et al. NATURE MEDICINE
- Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk
- (2020) Minta Thomas et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Biomarkers in Colorectal Cancer: Current Research and Future Prospects
- (2020) Olorunseun O. Ogunwobi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A new prognostic and predictive tool for shared decision making in stage III colon cancer
- (2020) Alberto F. Sobrero et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant Chemotherapy for Stage III Colon Cancer
- (2020) Julien Taieb et al. Cancers
- Outcomes of neoadjuvant chemoradiotherapy followed by radical resection for T4 colorectal cancer
- (2020) Chun-Ming Huang et al. World Journal of Gastrointestinal Oncology
- Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy
- (2020) Ching-Wen Huang et al. ONCOLOGY RESEARCH
- Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502).
- (2019) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional Effects of let-7g Expression in Colon Cancer Metastasis
- (2019) Che-Mai Chang et al. Cancers
- Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies
- (2019) J Taieb et al. ANNALS OF ONCOLOGY
- Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers
- (2019) M. Karoui et al. ANNALS OF SURGERY
- Association analyses identify 31 new risk loci for colorectal cancer susceptibility
- (2019) Philip J. Law et al. Nature Communications
- Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer
- (2019) Eduardo López-Urrutia et al. Frontiers in Oncology
- Neoadjuvant Chemotherapy for Locally Advanced T4 Colon Cancer: A Nationwide Propensity-Score Matched Cohort Analysis
- (2019) Jan-Marie de Gooyer et al. DIGESTIVE SURGERY
- Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study
- (2019) Jen-Pin Chuang et al. BMJ Open
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based study
- (2019) Elizabeth Alwers et al. Molecular Oncology
- AJCC 8th Edition: Colorectal Cancer
- (2018) Martin R. Weiser ANNALS OF SURGICAL ONCOLOGY
- Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy
- (2018) Claire Gallois et al. CLINICAL CANCER RESEARCH
- c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival
- (2018) Su Jin Lee et al. Clinical Colorectal Cancer
- Management and Outcome After Multivisceral Resections in Patients with Locally Advanced Primary Colon Cancer
- (2018) Emma Rosander et al. DISEASES OF THE COLON & RECTUM
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy
- (2018) Aziz Zaanan et al. JAMA Oncology
- Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data
- (2018) Manish Chand et al. World Journal of Gastrointestinal Oncology
- The Impact of a Multivisceral Resection and Adjuvant Therapy in Locally Advanced Colon Cancer
- (2018) Lieve G. J. Leijssen et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
- (2018) Romain Cohen et al. JAMA Oncology
- Neoadjuvant Chemotherapy Improves Survival in Patients with Clinical T4b Colon Cancer
- (2017) Ahmed Dehal et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Locally Advanced Colon Cancer: Evaluation of Current Clinical Practice and Treatment Outcomes at the Population Level
- (2017) Charlotte E.L. Klaver et al. Journal of the National Comprehensive Cancer Network
- Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- MicroRNA-1299 is a negative regulator of STAT3 in colon cancer
- (2017) Yong Wang et al. ONCOLOGY REPORTS
- Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer
- (2017) Chun-Ming Huang et al. Radiation Oncology
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function
- (2017) Ching-Wen Huang et al. Oncotarget
- Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer
- (2017) Fausto Petrelli et al. JAMA Oncology
- Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers
- (2017) Frank A. Sinicrope et al. JAMA Oncology
- ERBB2 alterations a new prognostic biomarker in stage III colon cancer from a FOLFOX based adjuvant trial (PETACC8)
- (2016) P. Laurent-Puig et al. ANNALS OF ONCOLOGY
- Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)
- (2016) Jeong Eun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy
- (2016) Quyen D. Chu et al. BMC CANCER
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials
- (2016) Susan D Richman et al. JOURNAL OF PATHOLOGY
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer
- (2016) Ming-Yii Huang et al. Translational Oncology
- New trends in molecular and cellular biomarker discovery for colorectal cancer
- (2016) Parisa Aghagolzadeh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Neoadjuvant chemotherapy in locally advanced colon cancer.A phase II trial
- (2015) Anders Jakobsen et al. ACTA ONCOLOGICA
- Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era
- (2015) Ethan B. Ludmir et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 - ECKINOXE trial
- (2015) Mehdi Karoui et al. BMC CANCER
- HGF-activated colonic fibroblasts mediates carcinogenesis of colonic epithelial cancer cells via PKC-cMET-ERK1/2-COX-2 signaling
- (2015) F. Li et al. CELLULAR SIGNALLING
- MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD
- (2015) Jie Chai et al. IUBMB LIFE
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According toBRAFMutation and Mismatch Repair Status of the MOSAIC Study
- (2015) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- The genomic landscape of response to EGFR blockade in colorectal cancer
- (2015) Andrea Bertotti et al. NATURE
- Knockdown of long non-coding RNA HOTAIR inhibits proliferation and invasiveness and improves radiosensitivity in colorectal cancer
- (2015) XIAO-DONG YANG et al. ONCOLOGY REPORTS
- LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy
- (2015) Yun-Ting Lou et al. PLoS One
- High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis
- (2015) HeLi Gao et al. TUMOR BIOLOGY
- Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer
- (2015) Ching-Wen Huang et al. World Journal of Surgical Oncology
- Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
- (2014) D. Klingbiel et al. ANNALS OF ONCOLOGY
- VEGF and Colon Cancer Growth Beyond Angiogenesis: Does VEGF Directly Mediate Colon Cancer Growth Via a Non-angiogenic Mechanism?
- (2014) Amrita Ahluwalia et al. CURRENT PHARMACEUTICAL DESIGN
- CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
- (2014) Stacey Shiovitz et al. GASTROENTEROLOGY
- LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway
- (2014) GUANGYU WANG et al. ONCOLOGY REPORTS
- Aberrant, ectopic expression of VEGF and VEGF receptors 1 and 2 in malignant colonic epithelial cells. Implications for these cells growth via an autocrine mechanism
- (2013) Amrita Ahluwalia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveilla006Ece, epidemiology, and end results (SEER) database
- (2013) Peng Gao et al. BMC CANCER
- Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
- (2013) C-Y Lu et al. BRITISH JOURNAL OF CANCER
- Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
- (2013) Y Takahashi et al. BRITISH JOURNAL OF CANCER
- Prognostic Significance of Partial Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
- (2013) Yen-Chien Lee et al. DISEASES OF THE COLON & RECTUM
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy
- (2013) Ming-Yii Huang et al. JOURNAL OF SURGICAL ONCOLOGY
- Oncologic Outcomes after Adjuvant Chemotherapy Using FOLFOX in MSI-H Sporadic Stage III Colon Cancer
- (2013) Seung Yeop Oh et al. WORLD JOURNAL OF SURGERY
- The Role of MicroRNAs in Colorectal Cancer
- (2012) Aaron J. Schetter et al. CANCER JOURNAL
- Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experience
- (2012) M. Cukier et al. EJSO
- Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
- (2012) Rolf Sauer et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
- (2012) FOxTROT Collaborative Group LANCET ONCOLOGY
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer
- (2012) Marina Antelo et al. PLoS One
- The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer
- (2012) Ching-Wen Huang et al. World Journal of Surgical Oncology
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Prognostic Value of ERCC1, Thymidylate Synthase, and Glutathione S-Transferase π for 5-FU/Oxaliplatin Chemotherapy in Advanced Colorectal Cancer
- (2010) Sung-Hyun Kim et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- DNA methylation markers in colorectal cancer
- (2010) Myoung Sook Kim et al. CANCER AND METASTASIS REVIEWS
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
- (2010) Bo Song et al. Molecular Cancer
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
- (2010) A. J. Levine et al. SCIENCE
- Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials
- (2009) Daniel Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data
- (2009) Leonard L. Gunderson et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
- (2009) B Song et al. ONCOGENE
- A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer
- (2008) Shuji Ogino et al. JNCI-Journal of the National Cancer Institute
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Suppression of non-small cell lung tumor development by the let-7 microRNA family
- (2008) M. S. Kumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The let-7 family of microRNAs
- (2008) Sarah Roush et al. TRENDS IN CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now